As the leader of the Ochsner Precision Cancer Therapies Program, Dr. Matrana focuses on treating patients with cancers of the genitourinary tract, lung cancer, gastrointestinal cancer, and other solid tumors. He is a native of New Orleans, who trained at MD Anderson Cancer Center in Houston where he served as Chief Fellow. His groundbreaking research has led to numerous peer-reviewed articles, chapters, and other publications in the field of genitourinary medical oncology. In addition to research and patient care, Dr. Matrana is an active medical educator who has spoken to groups around the world.

Dr. Johnson is the Deputy Director of Medical Oncology for the Precision Cancer Therapies Program. Dr. Johnson completed his internship and residency at Louisiana State University Health Sciences Center and completed his hematology/oncology fellowship at MD Anderson. He has special research interests include melanoma and strategies to overcome immunotherapy resistance and prevent immune-related adverse events. Dr. Johnson has multiple peer-reviewed articles and presentations at national meetings pertaining to the management and underlying mechanisms of immune toxicity. He is a clinical investigator focused on designing and implementing clinical trials intended to optimize the safety and efficacy of immune checkpoint inhibitors.

Dr. Jonathan Mizrahi received his medical degree from University of Florida College of Medicine in Gainesville and completed his residency at Barnes-Jewish Hospital at Washington University Medical Center in St. Louis. He completed his fellowship in hematology and oncology at MD Anderson Cancer Center in Houston. Dr. Mizrahi is board certified by the American Board of Internal Medicine. He has been on staff at Ochsner since August 2020 and specializes in hematology and oncology, with a particular clinical and research focus on cancers of the gastrointestinal tract, including pancreatic cancer.

Dr. John Cole completed his internship and residency at Ochsner and completed his hematology/oncology fellowship at Columbia Presbyterian Medical Center in New York. Dr. Cole is board certified in Internal Medicine, Hematology and Medical Oncology and has been on staff at Ochsner since 1989. He has been Principal Investigator of the Ochsner NCI Community Oncology Research Program (NCORP) since 2017 and is currently the Director of Clinical Cancer Research for Ochsner Health. He has a special clinical and research focus on breast cancer.

Carlie received a Bachelor of Science in nursing degree from Louisiana State University in New Orleans. While working as a registered nurse, she received a Master of Nursing practice degree from Southeastern Louisiana University. Prior to joining the hematology oncology team as a nurse practitioner, Carlie worked as a registered nurse for Ochsner's inpatient oncology/bone marrow transplant unit for six years and then Ochsner's chemo infusion team for two years. Carlie holds two nursing certifications: oncology certified nurse and blood & marrow transplant certified nurse. Carlie treats solid tumor cancer patients and is a nurse practitioner for the precision cancer therapies program. Her special areas of interest are hematology/oncology, cancer care, solid tumor oncology and early phase clinical trials.

Sharon Jerdonek is a clinical research coordinator for the Precision Cancer Therapies Program specializing in colorectal, pancreatic, liver, gastric/esophageal and head and neck cancers. She has worked in oncology since 1990 and has been with Ochsner’s PCTP since 2017.

Amanda Woolery is a clinical research coordinator for the Precision Cancer Therapies Program specializing in hematology as well as lung, breast and melanoma cancers. She has worked in oncology since 2006 after starting as a chemotherapy infusion nurse, and she has been with Ochsner’s PCTP since 2016.

Morgan Smith is a clinical research coordinator for the Precision Cancer Therapies Program specializing in colorectal, pancreatic and genitourinary cancers. She has worked in oncology since 2014 after working in the inpatient oncology unit and then as a chemotherapy infusion nurse here at Ochsner. She joined the Ochsner PCTP in 2021..

Christina Robinson is an associate clinical research coordinator for the Precision Cancer Therapies Program specializing in Strata Oncology’s next generation sequencing testing trial, genetic mutation, genomic profiling, pathology specimen retrieval and molecular tumor board. She has been working in oncology since 2016.

Kelly Lee has been the data coordinator for the Precision Cancer Therapies Program since 2019. She is responsible for entering research data for the trial sponsors specializing in solid tumors.

Kelly Killeen received a Bachelor of Arts degree in Psychology with a minor in Sociology from the University of New Orleans in 1990 and a Master of Social Work degree and a certificate in Gerontology from Tulane University in 1992. Kelly joined the Ochsner team in 1996 after working at a local skilled nursing facility and started working in oncology in 2008. She assists the patients in coping with their diagnosis of cancer, the emotions they may feel and the changes they may experience in their work, family, or other areas of their lives. Kelly links them with various resources as appropriate to their individual situations and needs.